DreamMapper
An Award winning app designed for PAP therapy support
DreamMapper
An Award winning app designed for PAP therapy support
Patient motivation is one of the most significant predictors of adherence to OSA treatment¹. If you are looking for ways to support and motivate your patients to stick to PAP therapy, encourage your patients to join over 2M registered DreamMapper users across the globe.
DreamMapper is designed to engage patients and help them take an active role in their therapy on the journey to reclaim their sleep.
Download now
Getting started is easy
Empower your patients
Therapy and compliance working together
Features
Getting started is easy
We've made it convenient for you to communicate the benefits of DreamMapper to your patients. At the patient-specific website, patients can access information about DreamMapper and log-in directly to their account.
Empower your patients
DreamMapper is our best sleep apnea engagement tool ever:
- 58.3% more people used their therapy every night when they used DreamMapper.*
- 283.3% higher success rate for users struggling with adherence to sleep therapy **
Patients can take an active role
As a care provider, you cannot always be there to ensure compliance. DreamMapper offers patients the opportunity to take an active role, by tracking their daily progress, setting goals and reminders, and acknowledging their achievements. The app's educational content offers support for general troubleshooting and common challenges with OSA. And to prepare for office visits, DreamMapper allows patients to generate reports that can be shared with their care team members.
Disclaimer
*19% of DreamMapper users used their therapy 100% of the nights over 90-days versus 12% for the Standard Care users, a 58.33% increase.
In a retrospective review conducted by Philips Respironics of the EncoreAnywhere database (see DreamMapper whitepaper) that compared DreamMapper patients (n=85,077) to users who did not use it (n=87,602).
**46% 90-day adherence rate for DreamMapper patients versus 12% for the Standard Care group, a 283.33% increase.
In a retrospective review conducted by Philips Respironics of the EncoreAnywhere database (see DreamMapper whitepaper) of struggling patients (n= 24,378).